AU2303402A - Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) - Google Patents
Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)Info
- Publication number
- AU2303402A AU2303402A AU2303402A AU2303402A AU2303402A AU 2303402 A AU2303402 A AU 2303402A AU 2303402 A AU2303402 A AU 2303402A AU 2303402 A AU2303402 A AU 2303402A AU 2303402 A AU2303402 A AU 2303402A
- Authority
- AU
- Australia
- Prior art keywords
- dopamine
- modulators
- receptors
- derivatives useful
- antipsychotic agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0027784A GB0027784D0 (en) | 2000-11-14 | 2000-11-14 | Compounds |
GB0031082A GB0031082D0 (en) | 2000-12-20 | 2000-12-20 | Compounds |
PCT/EP2001/013140 WO2002040471A2 (en) | 2000-11-14 | 2001-11-12 | Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2303402A true AU2303402A (en) | 2002-05-27 |
Family
ID=26245287
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2303402A Pending AU2303402A (en) | 2000-11-14 | 2001-11-12 | Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
AU2002223034A Ceased AU2002223034B2 (en) | 2000-11-14 | 2001-11-12 | Tetrahydrobenzazepine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents) |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002223034A Ceased AU2002223034B2 (en) | 2000-11-14 | 2001-11-12 | Tetrahydrobenzazepine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents) |
Country Status (20)
Country | Link |
---|---|
US (1) | US7429579B2 (en) |
EP (1) | EP1335915B1 (en) |
JP (1) | JP4272423B2 (en) |
KR (1) | KR20030045187A (en) |
CN (1) | CN1254474C (en) |
AR (1) | AR035369A1 (en) |
AT (1) | ATE382617T1 (en) |
AU (2) | AU2303402A (en) |
BR (1) | BR0115328A (en) |
CA (1) | CA2428844A1 (en) |
CZ (1) | CZ20031311A3 (en) |
DE (1) | DE60132235T2 (en) |
ES (1) | ES2298294T3 (en) |
HU (1) | HUP0302264A2 (en) |
IL (1) | IL155873A0 (en) |
MX (1) | MXPA03004243A (en) |
NO (1) | NO20032161L (en) |
NZ (1) | NZ525771A (en) |
PL (1) | PL362992A1 (en) |
WO (1) | WO2002040471A2 (en) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
AR040126A1 (en) | 2002-05-29 | 2005-03-16 | Glaxo Group Ltd | PHENYL SULFONYL COMPOUND, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT |
GB0212399D0 (en) * | 2002-05-29 | 2002-07-10 | Glaxo Group Ltd | Compounds |
GB0224083D0 (en) * | 2002-10-16 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
SI1572215T1 (en) | 2002-12-20 | 2010-01-29 | Venue Glaxo Group Ltd Glaxo We | BENZO?áD?åAZEPINE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS |
CN1805938B (en) | 2003-06-17 | 2010-06-16 | 艾尼纳制药公司 | Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases |
JP4920409B2 (en) | 2003-06-17 | 2012-04-18 | アリーナ ファーマシューティカルズ, インコーポレイテッド | Method for preparing 3-benzazepine |
US20050137186A1 (en) | 2003-12-18 | 2005-06-23 | Abbott Gmbh & Co. Kg. | Tetrahydrobenzazepines and their use |
JP4982184B2 (en) * | 2003-12-18 | 2012-07-25 | アボット ゲーエムベーハー ウント カンパニー カーゲー | Tetrahydrobenzazepine and their use in modulating dopamine D3 receptors |
AR047890A1 (en) | 2004-02-23 | 2006-03-01 | Glaxo Group Ltd | DERIVATIVES OF AZABICICLO [3.1.0] HEXANO AS MODULATORS OF DOPAMINE D3 RECEIVERS |
WO2005087764A1 (en) * | 2004-03-08 | 2005-09-22 | Glaxo Group Limited | Tetrahydrobenzazepine derivatives as modulators of dopamine d3 receptors (antipsychotic agents) |
GB0412314D0 (en) * | 2004-06-02 | 2004-07-07 | Glaxo Group Ltd | Compounds |
GB0413879D0 (en) | 2004-06-21 | 2004-07-21 | Glaxo Group Ltd | Compounds |
GB0414795D0 (en) * | 2004-07-01 | 2004-08-04 | Glaxo Group Ltd | Compounds |
EP1809597B1 (en) * | 2004-10-14 | 2012-01-11 | Abbott GmbH & Co. KG | Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
JP5173429B2 (en) * | 2004-12-09 | 2013-04-03 | ゼンション・リミテッド | Compound |
EA201200954A1 (en) | 2004-12-21 | 2013-05-30 | Арена Фармасьютикалз, Инк. | METHOD OF OBTAINING HYDROCHLORIDE (R) -8-CHLOR-1-METHYL-HALT-HYDROCHLORIDE (R) -8-CHLOR-1-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINA, PHARMACEUTICAL COMPOSITION ON ITS BASIS AND ITS APPLICATION |
GB0507601D0 (en) | 2005-04-14 | 2005-05-18 | Glaxo Group Ltd | Compounds |
GB0507602D0 (en) * | 2005-04-14 | 2005-05-18 | Glaxo Group Ltd | Compounds |
GB0507680D0 (en) | 2005-04-15 | 2005-05-25 | Glaxo Group Ltd | Compounds |
GB0512099D0 (en) * | 2005-06-14 | 2005-07-20 | Glaxo Group Ltd | Compounds |
GB0517187D0 (en) | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
GB0517191D0 (en) * | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
US8168782B2 (en) | 2006-04-03 | 2012-05-01 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto |
US8299241B2 (en) | 2006-12-05 | 2012-10-30 | Arena Pharmaceuticals, Inc. | Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof |
PE20091339A1 (en) | 2007-12-21 | 2009-09-26 | Glaxo Group Ltd | OXADIAZOLE DERIVATIVES WITH ACTIVITY ON S1P1 RECEPTORS |
WO2009111004A1 (en) | 2008-03-04 | 2009-09-11 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine |
WO2010007382A1 (en) * | 2008-07-18 | 2010-01-21 | Takeda Pharmaceutical Company Limited. | Benzazepine derivatives and their use as hstamine h3 antagonists |
US8952197B2 (en) | 2009-06-18 | 2015-02-10 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
GB0910674D0 (en) | 2009-06-19 | 2009-08-05 | Glaxo Group Ltd | Novel compounds |
UY33172A (en) | 2010-01-08 | 2011-07-29 | Takeda Pharmaceutical | DERIVATIVES OF BENZAZEPINE AND ITS USE AS HISTAMINE ANTAGONISTS H3 |
WO2011083315A1 (en) | 2010-01-08 | 2011-07-14 | Takeda Pharmaceutical Company Limited | Compounds and their use |
WO2011083316A1 (en) | 2010-01-08 | 2011-07-14 | Takeda Pharmaceutical Company Limited | Benzazepine derivatives for the treatment of central nervous system disorders |
KR20130112848A (en) | 2010-06-02 | 2013-10-14 | 아레나 파마슈티칼스, 인크. | Processes for the preparation of 5-ht2c receptor agonists |
SG10201506865WA (en) | 2010-09-01 | 2015-10-29 | Arena Pharm Inc | Non-hygroscopic salts of 5-ht2c agonists |
US9248133B2 (en) | 2010-09-01 | 2016-02-02 | Arena Pharmaceuticals, Inc. | Salts of lorcaserin with optically active acids |
SG10201506896RA (en) | 2010-09-01 | 2015-10-29 | Arena Pharm Inc | Administration of lorcaserin to individuals with renal impairment |
CN107669687A (en) | 2010-09-01 | 2018-02-09 | 艾尼纳制药公司 | 5 HT for body weight control2CThe modified release dosage form of activator |
AR088670A1 (en) | 2012-10-09 | 2014-06-25 | Arena Pharm Inc | WEIGHT CONTROL METHOD |
JP7015092B2 (en) | 2016-07-28 | 2022-02-02 | 塩野義製薬株式会社 | Nitrogen-containing fused ring compound having dopamine D3 receptor antagonistic activity |
KR20200112910A (en) | 2018-01-26 | 2020-10-05 | 시오노기 앤드 컴파니, 리미티드 | Condensed compounds with dopamine D3 receptor antagonism |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4233217A (en) | 1968-03-11 | 1980-11-11 | Pennwalt Corporation | Substituted 1,2,4,5-tetrahydro-3H, 3 benzazepines |
US4352754A (en) * | 1976-11-17 | 1982-10-05 | Smithkline Corporation | 3-Thienylmethyl-6-halo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
US4824839A (en) * | 1985-12-20 | 1989-04-25 | Smithkline Beckman Corporation | Sulfinyl and sulfonyl substituted 2,3,4,5 tetrahydro-1H-3-benzazepines and their use in treating gastrointestinal motility disorders |
ES2255311T3 (en) * | 1998-10-08 | 2006-06-16 | Smithkline Beecham Plc | USEFUL TETRAHYDROBENZAZEPIN DERIVATIVES AS MODULATORS OF D3 DOPAMINE RECEPTORS (ANTI-PSYCHOTIC AGENTS). |
TWI274750B (en) * | 1999-01-12 | 2007-03-01 | Abbott Gmbh & Co Kg | Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same |
-
2001
- 2001-11-12 CA CA002428844A patent/CA2428844A1/en not_active Abandoned
- 2001-11-12 AU AU2303402A patent/AU2303402A/en active Pending
- 2001-11-12 DE DE60132235T patent/DE60132235T2/en not_active Expired - Lifetime
- 2001-11-12 HU HU0302264A patent/HUP0302264A2/en unknown
- 2001-11-12 NZ NZ525771A patent/NZ525771A/en unknown
- 2001-11-12 MX MXPA03004243A patent/MXPA03004243A/en not_active Application Discontinuation
- 2001-11-12 WO PCT/EP2001/013140 patent/WO2002040471A2/en active IP Right Grant
- 2001-11-12 AR ARP010105272A patent/AR035369A1/en not_active Application Discontinuation
- 2001-11-12 CN CNB018219853A patent/CN1254474C/en not_active Expired - Fee Related
- 2001-11-12 PL PL01362992A patent/PL362992A1/en not_active Application Discontinuation
- 2001-11-12 BR BR0115328-5A patent/BR0115328A/en not_active IP Right Cessation
- 2001-11-12 AU AU2002223034A patent/AU2002223034B2/en not_active Ceased
- 2001-11-12 AT AT01996537T patent/ATE382617T1/en not_active IP Right Cessation
- 2001-11-12 CZ CZ20031311A patent/CZ20031311A3/en unknown
- 2001-11-12 US US10/416,377 patent/US7429579B2/en not_active Expired - Fee Related
- 2001-11-12 IL IL15587301A patent/IL155873A0/en unknown
- 2001-11-12 JP JP2002543482A patent/JP4272423B2/en not_active Expired - Fee Related
- 2001-11-12 KR KR10-2003-7006463A patent/KR20030045187A/en not_active Application Discontinuation
- 2001-11-12 ES ES01996537T patent/ES2298294T3/en not_active Expired - Lifetime
- 2001-11-12 EP EP01996537A patent/EP1335915B1/en not_active Expired - Lifetime
-
2003
- 2003-05-13 NO NO20032161A patent/NO20032161L/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE60132235D1 (en) | 2008-02-14 |
MXPA03004243A (en) | 2004-03-16 |
IL155873A0 (en) | 2003-12-23 |
BR0115328A (en) | 2004-04-06 |
US20040171606A1 (en) | 2004-09-02 |
CA2428844A1 (en) | 2002-05-23 |
US7429579B2 (en) | 2008-09-30 |
CZ20031311A3 (en) | 2004-04-14 |
JP4272423B2 (en) | 2009-06-03 |
NZ525771A (en) | 2004-11-26 |
EP1335915A2 (en) | 2003-08-20 |
ES2298294T3 (en) | 2008-05-16 |
CN1254474C (en) | 2006-05-03 |
PL362992A1 (en) | 2004-11-15 |
AU2002223034B2 (en) | 2005-06-23 |
NO20032161D0 (en) | 2003-05-13 |
AR035369A1 (en) | 2004-05-12 |
CN1486309A (en) | 2004-03-31 |
WO2002040471A3 (en) | 2002-08-22 |
KR20030045187A (en) | 2003-06-09 |
DE60132235T2 (en) | 2009-05-07 |
WO2002040471A2 (en) | 2002-05-23 |
WO2002040471A9 (en) | 2003-07-31 |
NO20032161L (en) | 2003-07-11 |
ATE382617T1 (en) | 2008-01-15 |
JP2004513946A (en) | 2004-05-13 |
EP1335915B1 (en) | 2008-01-02 |
HUP0302264A2 (en) | 2003-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2303402A (en) | Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) | |
IL142388A0 (en) | Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) | |
IL174419A0 (en) | Phenyl-piperazine derivatives as modulators of muscarinic receptors | |
ZA200408335B (en) | Pyrrolidinium derivatives as antagonists of M3 muscarinic receptors. | |
PL365377A1 (en) | Amide derivatives as nmda receptor antagonists | |
IL176215A0 (en) | Modulators of muscarinic receptors | |
AU2002231098A1 (en) | Nonpeptide agonists and antagonists of vasopressin receptors | |
EP1534379A4 (en) | Cap of tube for supplying liquid | |
NO995338D0 (en) | Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors | |
IL126747A0 (en) | Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors | |
AU4274401A (en) | Diphenylalkylamine derivatives useful as opioid delta receptor agonists | |
IL157412A0 (en) | Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands | |
PL371344A1 (en) | Benzenesulfonamide derivatives as antipsychotic agents | |
IL148623A0 (en) | Thienoisoxazolyl-and thienylpyrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists | |
EP1178815A4 (en) | Death domain containing receptors | |
GB0026578D0 (en) | Heterocyclic derivatives useful as pharmaceutical agents | |
AU2003227919A1 (en) | Dopamine receptor modulators as antipsychotic agents | |
AU2001240097A1 (en) | G protein-coupled receptors | |
AU4262799A (en) | Tetraisoquinololine derivatives as modulators of dopamine d3 receptors | |
AU2003273169A1 (en) | 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents | |
GB0130576D0 (en) | Dopamine D1 receptor agonist pro-drug compounds & derivatives | |
HK1053059A1 (en) | New use of imidazotriazinon derivatives | |
GB0020710D0 (en) | Dopamine D1 receptor agonist pro-drug compounds & derivatives | |
AU4992301A (en) | Novel g protein-coupled receptors | |
GB0117531D0 (en) | Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |